Showing results (21-30 of 158) with videos related to
Sort By:
Pageof 16
Annals of Neurology|May 19, 2001
Placebo-controlled clinical trials in multiple sclerosis: ethical considerations. National Multiple Sclerosis Society (USA) Task Force on Placebo-Controlled Clinical Trials in MSF D Lublin, S C ReingoldMultiple Sclerosis (Houndmills, Basingstoke, England)|May 26, 2023
MS becomes a treatable disease: 30 years laterFred D Lublin, Stephen C KriegerJournal of Clinical & Laboratory Immunology|November 1, 1980
Separation and properties of lymphocytes obtained from the central nervous systemF D Lublin, P H MaurerMultiple Sclerosis (Houndmills, Basingstoke, England)|January 1, 1997
Impairment of central and peripheral myelin in mitochondrial diseasesB Kalman, F D Lublin, H AlderJournal of the Neurological Sciences|September 1, 1996
Characterization of the mitochondrial DNA in patients with multiple sclerosisB Kalman, F D Lublin, H AlderNeurologic Clinics|February 21, 2002
Palliative care in patients with multiple sclerosisA B Ben-Zacharia, F D LublinMultiple Sclerosis (Houndmills, Basingstoke, England)|April 1, 1995
Mitochondrial DNA mutations in multiple sclerosisB Kalman, F D Lublin, H AlderNeurology|December 10, 2003
Effect of relapses on development of residual deficit in multiple sclerosisFred D Lublin, Monika Baier, Gary CutterJournal of Neuroimmunology|September 1, 1995
Characteristics of the T lymphocytes involved in experimental allergic encephalomyelitisB Kalman, H Alder, F D LublinContinuum (Minneapolis, Minn.)|August 7, 2013
Diagnosis and differential diagnosis of multiple sclerosisIlana B Katz Sand, Fred D LublinPageof 16